Weixian Chen

8PUBLICATIONS
1CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tissue engineeringPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 11, 2026
Utility of intercostal artery perforator flap in granulomatous lobular mastitis: a single-center retrospective study.

|Aug 13, 2026
Standard imaging-guided chest wall perforator flap reconstruction without intraoperative handheld Doppler for granulomatous lobular mastitis: a simplified approach for resource-limited settings.

|Apr 08, 2026
Genes From Epithelial-Mesenchymal Transition Predict Overall Survival Effectively in Breast Cancer: A Novel Risk Model Based on Initial Step of Tumor Metastasis.

Wei Liang, Zi-Ying Wang, Quan-Feng Shao

|Jun 12, 2025
Engineered EVs-Mediated miR-222 Targeting PTEN/FN1 Axis Reverses Anthracycline Resistance in HER2-Negative Breast Cancer.

Sujin Yang, Mei Yang, Quanfeng Shao

|Aug 09, 2020
MicroRNA-27a-3p Reverses Adriamycin Resistance by Targeting BTG2 and Activating PI3K/Akt Pathway in Breast Cancer Cells.

Bei Zhu, Weixian Chen, Yue Fu

|Jul 06, 2019
MicroRNA-222 promotes drug resistance to doxorubicin in breast cancer via regulation of miR-222/bim pathway.

Hong Dai, Ling-Yun Xu, Qi Qian

Pageof 2

Frequent Collaborators

1 joint publications

Sujin Yang